Consensus for Biomagnetics’ Integrated Optical Biosensor Continues to Build Among Leaders at Global Tuberculosis Surveillan...
December 13 2010 - 9:00AM
Business Wire
Biomagnetics Diagnostics Corp., (PINK SHEETS:BMGP - News) a
developer of revolutionary diagnostic systems and technology for
HIV, hepatitis, tuberculosis, Cholera and malaria detection, and
other innovative technologies, today announced CEO Clayton Hardman
attended a series of meetings on the important topic of diagnosing
and managing tuberculosis (“TB”) with industry leaders from the
Centers for Disease Control, the Foundation for New Innovative
Diagnostics (“FIND”), the World Health Organization and the
University of KwaZulu-Natal, South Africa and others, at a
Symposium hosted by Los Alamos National Laboratory.
While at the Global Tuberculosis Surveillance Workshop held this
month in Santa Fe, New Mexico, Biomagnetics Diagnostics Corp. met
with the engineering team from Los Alamos that built the bench-top
prototype unit of its Integrated Optical Biosensor (“IOBS”) for the
detection of TB. As a result of these meetings, development of the
“IOBS” moved forward as the engineers at Los Alamos agreed to meet
with Lathrop Engineering to fabricate a production model and
miniaturization unit of the IOBS. With the assistance of LANL the
Company also made arrangements to collaborate with other leaders in
the field to conduct validation studies on the IOBS device and TB
assay upon finalization, and assist with developing the HIV assay,
and assist with clinical trials and approvals.
Additionally, Mr. Hardman is planning to attend further meetings
where he expects to gain insights into the current status of
tuberculosis related activities, interests and goals at the Center
for Disease Control (“CDC”), one of the premier U.S. organizations
for the study and containment of prevalent global diseases.
Clayton Hardman, CEO of Biomagnetics Diagnostics Corp.
commented, “Attending the Global Tuberculosis Surveillance Workshop
sponsored by LANL has been a valuable experience. We are glad to
have been a part of this symposium and look forward to working with
the alliances to bring the IOBS unit to market.”
About Biomagnetics Diagnostics Corp.
Biomagnetics Diagnostics Corporation is an advanced medical
device and biotechnology company and an acquirer of other
innovative technologies. The Company is currently developing a
waveguide-based advanced integrated optical biosensor through its
cooperative research and development agreement with Los Alamos
National Security, LLC, which will initially be used for cholera,
tuberculosis, HIV and malaria diagnosis. More information on
Biomagnetics Diagnostics Corp. can be seen at
www.biomagneticsbmgp.com.
Biomagnetics Diagnostics (CE) (USOTC:BMGP)
Historical Stock Chart
From Apr 2024 to May 2024
Biomagnetics Diagnostics (CE) (USOTC:BMGP)
Historical Stock Chart
From May 2023 to May 2024
